Cargando…
Pre-induction LDH as a prognostic factor for outcome of high dose chemotherapy (HDCT) for germ cell tumours relapsing or refractory to conventional chemotherapy
Autores principales: | , , , , , , , |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group
2000
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2363262/ https://www.ncbi.nlm.nih.gov/pubmed/10864212 http://dx.doi.org/10.1054/bjoc.1999.1140 |
_version_ | 1782153659961835520 |
---|---|
author | Shamash, J Oliver, R T D Gallagher, C J Newland, A C Lister, T A Kelsey, S Gupta, R K O'Doherty, C A |
author_facet | Shamash, J Oliver, R T D Gallagher, C J Newland, A C Lister, T A Kelsey, S Gupta, R K O'Doherty, C A |
author_sort | Shamash, J |
collection | PubMed |
description | |
format | Text |
id | pubmed-2363262 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2000 |
publisher | Nature Publishing Group |
record_format | MEDLINE/PubMed |
spelling | pubmed-23632622009-09-10 Pre-induction LDH as a prognostic factor for outcome of high dose chemotherapy (HDCT) for germ cell tumours relapsing or refractory to conventional chemotherapy Shamash, J Oliver, R T D Gallagher, C J Newland, A C Lister, T A Kelsey, S Gupta, R K O'Doherty, C A Br J Cancer Letters to the Editor Nature Publishing Group 2000-06 2000-05-18 /pmc/articles/PMC2363262/ /pubmed/10864212 http://dx.doi.org/10.1054/bjoc.1999.1140 Text en Copyright © 2000 Cancer Research Campaign https://creativecommons.org/licenses/by/4.0/This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made.The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in a credit line to the material.If material is not included in the article’s Creative Commons license and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this license, visit https://creativecommons.org/licenses/by/4.0/. |
spellingShingle | Letters to the Editor Shamash, J Oliver, R T D Gallagher, C J Newland, A C Lister, T A Kelsey, S Gupta, R K O'Doherty, C A Pre-induction LDH as a prognostic factor for outcome of high dose chemotherapy (HDCT) for germ cell tumours relapsing or refractory to conventional chemotherapy |
title | Pre-induction LDH as a prognostic factor for outcome of high dose chemotherapy (HDCT) for germ cell tumours relapsing or refractory to conventional chemotherapy |
title_full | Pre-induction LDH as a prognostic factor for outcome of high dose chemotherapy (HDCT) for germ cell tumours relapsing or refractory to conventional chemotherapy |
title_fullStr | Pre-induction LDH as a prognostic factor for outcome of high dose chemotherapy (HDCT) for germ cell tumours relapsing or refractory to conventional chemotherapy |
title_full_unstemmed | Pre-induction LDH as a prognostic factor for outcome of high dose chemotherapy (HDCT) for germ cell tumours relapsing or refractory to conventional chemotherapy |
title_short | Pre-induction LDH as a prognostic factor for outcome of high dose chemotherapy (HDCT) for germ cell tumours relapsing or refractory to conventional chemotherapy |
title_sort | pre-induction ldh as a prognostic factor for outcome of high dose chemotherapy (hdct) for germ cell tumours relapsing or refractory to conventional chemotherapy |
topic | Letters to the Editor |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2363262/ https://www.ncbi.nlm.nih.gov/pubmed/10864212 http://dx.doi.org/10.1054/bjoc.1999.1140 |
work_keys_str_mv | AT shamashj preinductionldhasaprognosticfactorforoutcomeofhighdosechemotherapyhdctforgermcelltumoursrelapsingorrefractorytoconventionalchemotherapy AT oliverrtd preinductionldhasaprognosticfactorforoutcomeofhighdosechemotherapyhdctforgermcelltumoursrelapsingorrefractorytoconventionalchemotherapy AT gallaghercj preinductionldhasaprognosticfactorforoutcomeofhighdosechemotherapyhdctforgermcelltumoursrelapsingorrefractorytoconventionalchemotherapy AT newlandac preinductionldhasaprognosticfactorforoutcomeofhighdosechemotherapyhdctforgermcelltumoursrelapsingorrefractorytoconventionalchemotherapy AT listerta preinductionldhasaprognosticfactorforoutcomeofhighdosechemotherapyhdctforgermcelltumoursrelapsingorrefractorytoconventionalchemotherapy AT kelseys preinductionldhasaprognosticfactorforoutcomeofhighdosechemotherapyhdctforgermcelltumoursrelapsingorrefractorytoconventionalchemotherapy AT guptark preinductionldhasaprognosticfactorforoutcomeofhighdosechemotherapyhdctforgermcelltumoursrelapsingorrefractorytoconventionalchemotherapy AT odohertyca preinductionldhasaprognosticfactorforoutcomeofhighdosechemotherapyhdctforgermcelltumoursrelapsingorrefractorytoconventionalchemotherapy |